Peptinovo Biopharma
Dr. Ren Homan, PhD (Co-founder) is an experienced biotech entrepreneur with 30 years of drug discovery and development experience at Parke-Davis, Pfizer, and Esperion Therapeutics. Ren co-founded AlphaCore Pharma in 2007 with 2 partners to develop an enzyme replacement therapy and co-led the successful exit to AstraZeneca in 2013. Ren is the Chief Scientific Officer, responsible for developing and leading the research plan for advancing projects from concept and laboratory work to treatment of patients.
This person is not in any offices
Peptinovo Biopharma
1 followers
Peptinovo Biopharma Inc. has invented and patented a targeted, drug-delivery platform: Peptide-Amphiphile Lipid Micelle (PALM) that reduces or eliminates chemotherapy-induced peripheral neuropathy (CIPN), one of the most serious side effects threatening treatment outcomes for world-leading chemotherapy drugs like paclitaxel.